tiprankstipranks
Advertisement
Advertisement
InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
PremiumCompany AnnouncementsInspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
7d ago
InspireMD announces FDA approval of IDE application for CGUARDIANS III study
Premium
The Fly
InspireMD announces FDA approval of IDE application for CGUARDIANS III study
7d ago
InspireMD Establishes New $75 Million ATM Program
Premium
Company Announcements
InspireMD Establishes New $75 Million ATM Program
1M ago
InspireMD reports Q4 EPS (14c), consensus (19c)
PremiumThe FlyInspireMD reports Q4 EPS (14c), consensus (19c)
2M ago
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
Premium
The Fly
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
2M ago
Is NSPR a Buy, Before Earnings?
Premium
Pre-Earnings
Is NSPR a Buy, Before Earnings?
2M ago
InspireMD announces publication of C-GUARDIANS trial
PremiumThe FlyInspireMD announces publication of C-GUARDIANS trial
4M ago
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer?
Premium
Company Announcements
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer?
5M ago
BioCardia appoints Slosman to its Board of Directors
Premium
The Fly
BioCardia appoints Slosman to its Board of Directors
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100